Literature DB >> 30868284

Gastric Neuroendocrine Tumors (Carcinoids).

Craig R Gluckman1, David C Metz2.   

Abstract

PURPOSE OF REVIEW: The diagnosis of gastric neuroendocrine tumors (NETs) is being made with increased frequency likely as a result of more upper endoscopies being done for unrelated reasons. It is therefore vital that gastroenterologists become familiar with the basic work-up and management of patients found to have these tumors. This review describes the classification, pathophysiology, clinical characteristics, and treatment options of the different gastric NETs. RECENT
FINDINGS: In addition to the three traditional subtypes of gastric NETs, additional cases associated with achlorhydria and appropriate hypergastrinemia may exist. The management of gastric NETs between 1 and 2 cm in size remains controversial and needs to be individualized. Gastric NETs are uncommon but are now diagnosed more frequently. This review highlights the role of hypergastrinemia in their development and the controversies around their management.

Entities:  

Keywords:  Gastric carcinoid; Hypergastrinemia; Netazepide; Neuroendocrine tumor (NET)

Mesh:

Substances:

Year:  2019        PMID: 30868284     DOI: 10.1007/s11894-019-0684-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  9 in total

Review 1.  Diagnosis and Surgical Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: A Literature Review.

Authors:  Shuzo Kohno
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment.

Authors:  Marton Doleschall; Aniko Somogyi; Zoltan Herold; Magdolna Herold; Klara Rosta
Journal:  Diabetol Metab Syndr       Date:  2020-07-14       Impact factor: 3.320

3.  Epidemiology of neuroendocrine tumors of the appendix in the USA: a population-based national study (2014-2019).

Authors:  Motasem Alkhayyat; Mohannad Abou Saleh; Wendy Coronado; Mohammad Abureesh; Mohammad Zmaili; Thabet Qapaja; Ashraf Almomani; George Khoudari; Emad Mansoor; Gregory Cooper
Journal:  Ann Gastroenterol       Date:  2021-06-14

4.  Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.

Authors:  Kenichi Iwasaki; Edward Barroga; Masaya Enomoto; Kazushige Tsurui; Yota Shimoda; Moe Matsumoto; Kenta Miyoshi; Yoshihiro Ota; Jun Matsubayashi; Yuichi Nagakawa
Journal:  World J Surg Oncol       Date:  2022-05-24       Impact factor: 3.253

5.  Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis.

Authors:  Ping Liang; Chuou Xu; Fangqin Tan; Shichao Li; Mingzhen Chen; Daoyu Hu; Ihab Kamel; Yaqi Duan; Zhen Li
Journal:  Cancer Med       Date:  2020-12-01       Impact factor: 4.452

Review 6.  Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review.

Authors:  Francesco Panzuto; Ludovica Magi; Gianluca Esposito; Maria Rinzivillo; Bruno Annibale
Journal:  Gastroenterol Res Pract       Date:  2021-03-30       Impact factor: 2.260

7.  Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis.

Authors:  Dae Gon Ryu; Su Jin Kim; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam; Si Hak Lee; Sun Hwi Hwang
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

8.  Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Western Center Case Series.

Authors:  Marcus Fernando Kodama Pertille Ramos; Marina Alessandra Pereira; Arthur Youssif Mota Arabi; Melissa Mello Mazepa; Andre Roncon Dias; Ulysses Ribeiro; Bruno Zilberstein; Sergio Carlos Nahas
Journal:  Med Sci (Basel)       Date:  2021-06-25

9.  Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.

Authors:  Zoltan Herold; Magdolna Herold; Peter Nagy; Attila Patocs; Marton Doleschall; Aniko Somogyi
Journal:  J Diabetes Investig       Date:  2020-02-03       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.